Clinical Endocrinology · 2010 · 64 citations · 30 references
MedicineEndocrinologyGynecologyMenstrual DisordersReproductive EndocrinologyWomen's HealthCardiovascular DiseaseCoronary Artery DiseaseOvarian DisordersPolycystic Ovary SyndromeAtherosclerosis RiskAtherosclerotic Risk AssessmentCardiovascular Risk MarkersCoronary Artery Calcium ScorePolycystic Ovarian MorphologyPrevalence EstimationReproductive Age WomenSubclinical Atherosclerosis
OBJECTIVE: Polycystic ovarian syndrome (PCOS), the most common endocrinopathy of young women, is characterized by androgen excess and is frequently associated with cardiovascular risk factors. However, it is unclear whether PCOS is a risk factor for atherosclerosis. We sought to determine in a multiethnic population-based sample whether women with PCOS have greater measures of subclinical atherosclerosis than women without PCOS. DESIGN: Cross-sectional study of a nested cohort from the Dallas Heart Study (2000-2002). PARTICIPANTS: Women between the ages of 35 and 49 (n = 827). PCOS was defined by Rotterdam criteria. The normal control group had regular menses, total testosterone <2·78 nmol/l, no signs of hirsutism and no polycystic ovarian morphology by magnetic resonance imaging (MRI). MEASUREMENTS: Subclinical atherosclerosis defined as coronary artery calcium (CAC) by computed tomography and abdominal aortic plaque by MRI. RESULTS: The prevalence of PCOS in Dallas County was 19·6% (n = 144), and 8·0% (n = 56) had both oligomenorrhea and hyperandrogenism. Women with PCOS had higher body mass index, blood pressure, insulin and leptin than regularly cycling controls. Despite a greater prevalence of cardiovascular risk factors, women with PCOS did not have a greater prevalence of CAC > 10 Agatston units (PCOS 5%, controls 6·3%, P = 0·74) or abdominal aortic plaque (PCOS 25·8%, controls 34·4%, P = 0·13) than controls. CONCLUSIONS: In a large, multiethnic, population-based sample of premenopausal women, PCOS, defined by Rotterdam criteria, was not associated with a higher prevalence of coronary artery calcium or abdominal aortic plaque.
30
Ricardo Azziz, Enrico Carmina, Didier Dewailly et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 2.1K citations · Full text
Medicine, Endocrinology, Gynecology +11
Effects of Testosterone on Coronary Vasomotor Regulation in Men With Coronary Heart Disease
Carolyn Webb, John G. McNeill, Christopher S. Hayward et al. · Circulation · 1999 · 452 citations · Full text
Medicine, Cardiology, Endocrinology +17